Consultants in Neurology

Northbrook, Illinois 60062

0 studies enrolling now · 9 studies all time

What they study most

Central Neuropathic Pain, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Myasthenia Gravis, Pseudobulbar Affect (PBA), Relapsing Multiple Sclerosis

Studies at this site

• Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS — Running, not enrolling
• A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis — Running, not enrolling
• Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy — Completed
• A Study of TAK-079 in People With Generalized Myasthenia Gravis — Completed
• Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis — Completed
• Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis — Completed
• Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) — Completed
• Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS — Completed
• Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple Sclerosis — Completed